Your browser doesn't support javascript.
loading
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
Hettmer, Simone; Linardic, Corinne M; Kelsey, Anna; Rudzinski, Erin R; Vokuhl, Christian; Selfe, Joanna; Ruhen, Olivia; Shern, Jack F; Khan, Javed; Kovach, Alexander R; Lupo, Philip J; Gatz, Susanne A; Schäfer, Beat W; Volchenboum, Samuel; Minard-Colin, Véronique; Koscielniak, Ewa; Hawkins, Douglas S; Bisogno, Gianni; Sparber-Sauer, Monika; Venkatramani, Rajkumar; Merks, Johannes H M; Shipley, Janet.
Afiliação
  • Hettmer S; Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Germany.
  • Linardic CM; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA; Department of Pharmacology and Cancer Biology; Duke University of Medicine, Durham, NC, USA.
  • Kelsey A; Department of Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester Foundation Trust, Manchester, UK.
  • Rudzinski ER; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA.
  • Vokuhl C; Section of Pediatric Pathology, Department of Pathology, University Hospital Bonn, Germany.
  • Selfe J; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Ruhen O; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Shern JF; Genetics Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA; Pediatric Oncology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Khan J; Genetics Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Kovach AR; Department of Pharmacology and Cancer Biology; Duke University of Medicine, Durham, NC, USA.
  • Lupo PJ; Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Gatz SA; Institute of Cancer and Genomic Sciences, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
  • Schäfer BW; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Volchenboum S; Department of Pediatrics, University of Chicago, USA.
  • Minard-Colin V; Department of Pediatrics, Institut Gustave-Roussy, 94805 Villejuif Cedex, France.
  • Koscielniak E; Klinikum der Landeshauptstadt Stuttgart GKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Stuttgart, Germany; Medizinische Fakultät, University of Tübingen, Germany.
  • Hawkins DS; Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Bisogno G; Hematology Oncology Division, Department of Women's and Children's Health, University of Padova, Padua, Italy.
  • Sparber-Sauer M; Klinikum der Landeshauptstadt Stuttgart GKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Stuttgart, Germany; Medizinische Fakultät, University of Tübingen, Germany.
  • Venkatramani R; Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
  • Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Shipley J; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK. Electronic address: janet.shipley@icr.ac.uk.
Eur J Cancer ; 172: 367-386, 2022 09.
Article em En | MEDLINE | ID: mdl-35839732
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Neoplasias de Tecidos Moles / Rabdomiossarcoma Embrionário Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Neoplasias de Tecidos Moles / Rabdomiossarcoma Embrionário Idioma: En Ano de publicação: 2022 Tipo de documento: Article